factually
Index/Topics/Novo Nordisk semaglutide trials

Novo Nordisk semaglutide trials

Novo Nordisk's semaglutide trials for Alzheimer's disease, including the number of patients and outcomes

Fact-Checks

2 results
Feb 6, 2026

Which Alzheimer’s treatments are in phase 3 trials with potential 2026 readouts and who are the funders?

Several high‑profile Phase 3 Alzheimer’s trials could report results in 2026, including ’s anti‑amyloid , ’s EVOKE program, ’s pivotal study, the POLARIS‑AD trial of AR1001, and a phase 3 trial; fundi...

Jan 13, 2026

Wegovy pill effectiveness for weight loss

The FDA’s approval of the oral Wegovy (semaglutide) pill is grounded in the phase 3 OASIS 4 trial, in which adults with overweight or obesity — but without diabetes — lost substantially more weight on...